Scandiatransplant Exchange Program (STEP): Development and Results From an International Kidney Exchange Program

Autor: Ilse Duus Weinreich, BSc, Tommy Andersson, PhD, Margrét Birna Andrésdóttir, MD, PhD, Mats Bengtsson, MD, PhD, Alireza Biglarnia, MD, PhD, Claus Bistrup, MD, PhD, Line Boulland, MD, PhD, Helle Bruunsgaard, MD, PhD, Ilkka Helanterä, MD, PhD, Kulli Kölvald, MD, PhD, Jouni Lauronen, MD, PhD, Jørn Petter Lindahl, MD, PhD, Karin Skov, MD, PhD, Søren Schwarz Sørensen, MD, PhD, Lars Wennberg, MD, PhD, Per Lindner, MD, PhD

Publikováno v: Transplantation Direct, Vol 9, Iss 11, p e1549 (2023)

Background. Kidney transplant candidates may be incompatible with their intended living donors because of the presence of antibodies against HLA and/or ABO. To increase the possibility of finding an acceptable kidney donor for these patients, the Sca

Externí odkaz: https://doaj.org/article/9c981eeca3c24f7ea1d94c4201833091

Mismatches in Gene Deletions and Kidney-related Proteins as Candidates for Histocompatibility Factors in Kidney Transplantation

Autor: Salla, Markkinen, Ilkka, Helanterä, Jouni, Lauronen, Marko, Lempinen, Jukka, Partanen, Kati, Hyvärinen

Publikováno v: Kidney International Reports. 7:2484-2494

Publisher Copyright: © 2022 International Society of Nephrology Introduction: The genomic mismatch level between donor and recipient may be associated with the risk of rejection and graft survival. We determined the association of genome-level match

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b2ce996b446d1c0efeb269f467e4953
https://doi.org/10.1016/j.ekir.2022.08.032

Scandiatransplant acceptable mismatch program-10 years with an effective strategy for transplanting highly sensitized patients

Autor: Ilse Weinreich, Mats Bengtsson, Jouni Lauronen, Christian Naper, Kaie Lokk, Ilkka Helanterä, Margrét Birna Andrésdóttir, Søren Schwartz Sørensen, Lars Wennberg, Anna Varberg Reisæter, Bjarne Møller, Pernille Koefoed-Nielsen

Publikováno v: Weinreich, I, Bengtsson, M, Lauronen, J, Naper, C, Lokk, K, Helanterä, I, Andrésdóttir, M B, Sørensen, S S, Wennberg, L, Reisaeter, A V, Møller, B & Koefoed-Nielsen, P 2022, ' Scandiatransplant acceptable mismatch program-10 years with an effective strategy for transplanting highly sensitized patients ', American Journal of Transplantation, vol. 22, no. 12, pp. 2869-2879 . https://doi.org/10.1111/ajt.17182
Weinreich, I, Bengtsson, M, Lauronen, J, Naper, C, Lokk, K, Helanterä, I, Andrésdóttir, M B, Sørensen, S S, Wennberg, L, Reisæter, A V, Møller, B & Koefoed-Nielsen, P 2022, ' Scandiatransplant acceptable mismatch program—10 years with an effective strategy for transplanting highly sensitized patients ', American Journal of Transplantation, vol. 22, no. 12, pp. 2869-2879 . https://doi.org/10.1111/ajt.17182

In March 2009, the Scandiatransplant acceptable mismatch program (STAMP) was introduced as a strategy toward improving kidney allocation to highly sensitized patients. Patients with a transplantability score ≤ 2% are potential candidates for the pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8bae2e2efc070136ecc3dba03d10494
http://hdl.handle.net/10138/354246

Shorter Cold Ischemia Time in Deceased Donor Kidney Transplantation Reduces the Incidence of Delayed Graft Function Especially Among Highly Sensitized Patients and Kidneys From Older Donors

Autor: Timo Saarinen, Juha Peräsaari, Jouni Lauronen, Ilkka Helanterä, Taina Jaatinen, Marko Lempinen

Publikováno v: Transplantation Proceedings. 52:42-49

Background. Long cold ischemia time (CIT) is the most important factor contributing to delayed graft function (DGF) after kidney transplant. Improvements in pretransplant procedures may reduce CIT and improve clinical outcome. Materials and Methods.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d92152e4c0cf5f212087cc68601a8f92
https://doi.org/10.1016/j.transproceed.2019.11.025

Development of Human Leukocyte Antigen (HLA) Antibodies Against Vascular Homograft Donor in Pediatric Heart Transplant Recipients

Autor: Jaana Pihkala, Alireza Raissadati, Timo Jahnukainen, Jouni Lauronen, Hannu Jalanko, Juha Puntila, Tommi Pätilä, Ilkka Mattila, Elisa Ylinen, Jukka T. Salminen

Publikováno v: Annals of Transplantation

Background: The appearance of human leukocyte antigen (HLA) antibodies after solid organ transplantation predisposes recipients to graft dysfunction. In theory, vascular homografts, which are widely used in children with congenital heart defects, may

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::488e363ae02e072e031efb5320e93b77
https://doi.org/10.12659/aot.917232